BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27003294)

  • 1. Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris.
    Borgeraas H; Hertel JK; Svingen GF; Pedersen ER; Seifert R; Nygård O; Hjelmesæth J
    PLoS One; 2016; 11(3):e0152029. PubMed ID: 27003294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
    Borgeraas H; Hertel JK; Seifert R; Berge RK; Bohov P; Ueland PM; Nygård O; Hjelmesæth J
    Lipids Health Dis; 2016 Feb; 15():38. PubMed ID: 26920731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study.
    Borgeraas H; Hertel JK; Svingen GF; Seifert R; Pedersen EK; Schartum-Hansen H; Hjelmesæth J; Nygård O
    BMC Cardiovasc Disord; 2014 May; 14():68. PubMed ID: 24885137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.
    Surdacki A; Kruszelnicka O; Rakowski T; Jaźwińska-Kozuba A; Dubiel JS
    Cardiovasc Diabetol; 2013; 12():64. PubMed ID: 23578341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
    Böger RH; Sullivan LM; Schwedhelm E; Wang TJ; Maas R; Benjamin EJ; Schulze F; Xanthakis V; Benndorf RA; Vasan RS
    Circulation; 2009 Mar; 119(12):1592-600. PubMed ID: 19289633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
    Bjørnestad EØ; Borsholm RA; Svingen GFT; Pedersen ER; Seifert R; Midttun Ø; Ueland PM; Tell GS; Bønaa KH; Nygård O
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction.
    Bergheanu SC; van der Laarse A; van der Bom JG; van der Hoeven BL; le Cessie S; de Jong MG; Liem SS; Schalij MJ; Jukema JW
    Dis Markers; 2011; 30(5):245-52. PubMed ID: 21734344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
    Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
    Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate Dehydrogenase 1 Polymorphisms Modify the Associations of Plasma Glycine and Serine With Risk of Acute Myocardial Infarction in Patients With Stable Angina Pectoris in WENBIT (Western Norway B Vitamin Intervention Trial).
    Ding Y; Pedersen ER; Svingen GF; Helgeland Ø; Gregory JF; Løland KH; Meyer K; Tell GS; Ueland PM; Nygård OK
    Circ Cardiovasc Genet; 2016 Dec; 9(6):541-547. PubMed ID: 27872106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease.
    Svingen GF; Schartum-Hansen H; Ueland PM; Pedersen ER; Seifert R; Ebbing M; Bønaa KH; Mellgren G; Nilsen DW; Nordrehaug JE; Øyen J; Nygård O
    Eur J Prev Cardiol; 2015 Jun; 22(6):743-52. PubMed ID: 24671904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
    Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
    Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris.
    Schartum-Hansen H; Pedersen ER; Svingen GF; Ueland PM; Seifert R; Ebbing M; Strand E; Bleie Ø; Nygård O
    Eur J Prev Cardiol; 2015 May; 22(5):606-14. PubMed ID: 24595862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris.
    Ding Y; Svingen GF; Pedersen ER; Gregory JF; Ueland PM; Tell GS; Nygård OK
    J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A.
    Olsen T; Vinknes KJ; Svingen GF; Pedersen ER; Dhar I; Tell GS; Blomhoff R; Ueland PM; Midttun Ø; Refsum H; Nygård OK
    Eur J Prev Cardiol; 2018 Oct; 25(15):1612-1620. PubMed ID: 30014716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
    Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
    Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
    Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC
    Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.